Premium
P2‐309: Correction of ApoE4 dysfunction and reversal of Alzheimer's disease phenotype and cognition in ApoE4 target replacement mice by cogpepb, an abca1 agonist peptide derived from the lipid binding segment of ApoE
Author(s) -
Boehm-Cagan Anat,
Johansson Jan O.,
Bielicki John K.,
Michaelson Daniel M.
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.851
Subject(s) - apolipoprotein e , agonist , abca1 , medicine , placebo , endocrinology , hippocampus , neuroscience , pharmacology , psychology , disease , transporter , biology , pathology , receptor , biochemistry , gene , alternative medicine